- Home
- SQNS vs CGTX Comparison
SQNS vs CGTX Comparison
Compare SQNS & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SQNS
- CGTX
- Stock Information
- Founded
- SQNS 2003
- CGTX 2007
- Country
- SQNS France
- CGTX United States
- Employees
- SQNS N/A
- CGTX N/A
- Industry
- SQNS Semiconductors
- CGTX Biotechnology: Pharmaceutical Preparations
- Sector
- SQNS Technology
- CGTX Health Care
- Exchange
- SQNS Nasdaq
- CGTX Nasdaq
- Market Cap
- SQNS 140.2M
- CGTX 126.2M
- IPO Year
- SQNS 2011
- CGTX 2021
- Fundamental
- Price
- SQNS $9.96
- CGTX $1.53
- Analyst Decision
- SQNS Buy
- CGTX Strong Buy
- Analyst Count
- SQNS 1
- CGTX 3
- Target Price
- SQNS $35.00
- CGTX $2.83
- AVG Volume (30 Days)
- SQNS 376.5K
- CGTX 3.3M
- Earning Date
- SQNS 11-04-2025
- CGTX 11-12-2025
- Dividend Yield
- SQNS N/A
- CGTX N/A
- EPS Growth
- SQNS N/A
- CGTX N/A
- EPS
- SQNS 18.54
- CGTX N/A
- Revenue
- SQNS $37,325,000.00
- CGTX N/A
- Revenue This Year
- SQNS N/A
- CGTX N/A
- Revenue Next Year
- SQNS $89.05
- CGTX N/A
- P/E Ratio
- SQNS $0.53
- CGTX N/A
- Revenue Growth
- SQNS 32.07
- CGTX N/A
- 52 Week Low
- SQNS $7.30
- CGTX $0.22
- 52 Week High
- SQNS $58.30
- CGTX $3.83
- Technical
- Relative Strength Index (RSI)
- SQNS 48.86
- CGTX 46.69
- Support Level
- SQNS $9.40
- CGTX $1.29
- Resistance Level
- SQNS $10.00
- CGTX $1.61
- Average True Range (ATR)
- SQNS 0.58
- CGTX 0.14
- MACD
- SQNS 0.25
- CGTX -0.01
- Stochastic Oscillator
- SQNS 55.66
- CGTX 70.24
About SQNS Sequans Communications S.A.
Sequans Communications SA is a designer, developer, and supplier of cellular semiconductor solutions for broadband Internet of Things (IoT) markets. Its offer 5G/4G chips and modules fully optimized for non-smartphone devices. The company covers applications such as smart mobility and logistics, smart utility meters, smart cities, smart industries, e-health and wellness, and smart homes to name few. The Company has one operating segment, which is the design and marketing of semiconductor components for cellular wireless systems. Its geographical segments are Taiwan, Korea, China (including Hong Kong), the Rest of Asia, the United States and the Rest of the world.
About CGTX Cognition Therapeutics Inc.
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.